今年由我国主导完成的ISO国际标准《中药编码规则》正式发布

2016-03-31 佚名 医谷

近日,由我国主导的《中药编码系统——第一部分:中药编码规则》(ISO 18668-1)经过为期3个月的ISO最终国际标准草案投票,由国际标准化组织正式发布,标志着中药在数字化、标准化、信息化方面迈出了第一步。 该项目由深圳市卫生计生委副巡视员廖利平领衔申报,深圳市卫生计生委、深圳标准技术研究院、中国中医科学院等43个单位共77名专家,以及美国、加拿大、澳大利亚等20多个成员国的专家,历经了3

近日,由我国主导的《中药编码系统——第一部分:中药编码规则》(ISO 18668-1)经过为期3个月的ISO最终国际标准草案投票,由国际标准化组织正式发布,标志着中药在数字化、标准化、信息化方面迈出了第一步。

该项目由深圳市卫生计生委副巡视员廖利平领衔申报,深圳市卫生计生委、深圳标准技术研究院、中国中医科学院等43个单位共77名专家,以及美国、加拿大、澳大利亚等20多个成员国的专家,历经了3年多的时间联合参与完成。该标准的批准发布,是今年首个我国主导完成的中医药ISO国际标准。

据悉,《中药编码系统——第一部分:中药编码规则》以17位阿拉伯数字,分类表达中药的品种来源、药用部位、品种类别及其规格、炮制方法等特定编码技术分类及其含义,主要包括四个部分:国际编码、中国编码规则、药品标准、校验码。中药编码规则适用于中药材、中药饮片、中药配方颗粒的编码。以标准的形式将中医药的特色和优势固化下来,具有唯一性、科学性、可扩展性、一致性、稳定性等特点,其信息简短、准确、安全,有望为中医药走向世界,推动中医药国际化、现代化以及保障药品安全提供支撑。

廖利平表示,该标准的批准发布具有重大的现实意义,中国负责主导6项国际标准,《中药编码规则》是这些标准的顶层设计,可为中医药和各国传统医药提供数字化编码依据和技术标准,同时,将会加速推进《中药材编码》《中药饮片编码》《中药配方颗粒编码》等5个国际标准的出台。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1951321, encodeId=7fd7195132134, content=<a href='/topic/show?id=18ad4112322' target=_blank style='color:#2F92EE;'>#国际标准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41123, encryptionId=18ad4112322, topicName=国际标准)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=570c172, createdName=tigerlr98, createdTime=Fri Jul 08 20:27:00 CST 2016, time=2016-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1584638, encodeId=b297158463808, content=<a href='/topic/show?id=83f5e9250e9' target=_blank style='color:#2F92EE;'>#编码#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79250, encryptionId=83f5e9250e9, topicName=编码)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b10a17056098, createdName=12498f6em12暂无昵称, createdTime=Sat Apr 02 00:27:00 CST 2016, time=2016-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75036, encodeId=aaece503661, content=中药编码,有利于药物管理和查询。, beContent=null, objectType=article, channel=null, level=null, likeNumber=171, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160313/IMG56E50DEC424F44672.jpg, createdBy=ce5b1699635, createdName=Lisa971, createdTime=Thu Mar 31 16:18:00 CST 2016, time=2016-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75035, encodeId=81dde5035b4, content=中药编码,有利于药物的管理,查询!, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160313/IMG56E50DEC424F44672.jpg, createdBy=ce5b1699635, createdName=Lisa971, createdTime=Thu Mar 31 16:14:00 CST 2016, time=2016-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75008, encodeId=9234e500889, content=终于有了, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Thu Mar 31 12:44:00 CST 2016, time=2016-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75007, encodeId=bd82e5007a2, content=非常的好, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Thu Mar 31 12:43:00 CST 2016, time=2016-03-31, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1951321, encodeId=7fd7195132134, content=<a href='/topic/show?id=18ad4112322' target=_blank style='color:#2F92EE;'>#国际标准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41123, encryptionId=18ad4112322, topicName=国际标准)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=570c172, createdName=tigerlr98, createdTime=Fri Jul 08 20:27:00 CST 2016, time=2016-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1584638, encodeId=b297158463808, content=<a href='/topic/show?id=83f5e9250e9' target=_blank style='color:#2F92EE;'>#编码#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79250, encryptionId=83f5e9250e9, topicName=编码)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b10a17056098, createdName=12498f6em12暂无昵称, createdTime=Sat Apr 02 00:27:00 CST 2016, time=2016-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75036, encodeId=aaece503661, content=中药编码,有利于药物管理和查询。, beContent=null, objectType=article, channel=null, level=null, likeNumber=171, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160313/IMG56E50DEC424F44672.jpg, createdBy=ce5b1699635, createdName=Lisa971, createdTime=Thu Mar 31 16:18:00 CST 2016, time=2016-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75035, encodeId=81dde5035b4, content=中药编码,有利于药物的管理,查询!, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160313/IMG56E50DEC424F44672.jpg, createdBy=ce5b1699635, createdName=Lisa971, createdTime=Thu Mar 31 16:14:00 CST 2016, time=2016-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75008, encodeId=9234e500889, content=终于有了, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Thu Mar 31 12:44:00 CST 2016, time=2016-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75007, encodeId=bd82e5007a2, content=非常的好, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Thu Mar 31 12:43:00 CST 2016, time=2016-03-31, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1951321, encodeId=7fd7195132134, content=<a href='/topic/show?id=18ad4112322' target=_blank style='color:#2F92EE;'>#国际标准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41123, encryptionId=18ad4112322, topicName=国际标准)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=570c172, createdName=tigerlr98, createdTime=Fri Jul 08 20:27:00 CST 2016, time=2016-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1584638, encodeId=b297158463808, content=<a href='/topic/show?id=83f5e9250e9' target=_blank style='color:#2F92EE;'>#编码#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79250, encryptionId=83f5e9250e9, topicName=编码)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b10a17056098, createdName=12498f6em12暂无昵称, createdTime=Sat Apr 02 00:27:00 CST 2016, time=2016-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75036, encodeId=aaece503661, content=中药编码,有利于药物管理和查询。, beContent=null, objectType=article, channel=null, level=null, likeNumber=171, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160313/IMG56E50DEC424F44672.jpg, createdBy=ce5b1699635, createdName=Lisa971, createdTime=Thu Mar 31 16:18:00 CST 2016, time=2016-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75035, encodeId=81dde5035b4, content=中药编码,有利于药物的管理,查询!, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160313/IMG56E50DEC424F44672.jpg, createdBy=ce5b1699635, createdName=Lisa971, createdTime=Thu Mar 31 16:14:00 CST 2016, time=2016-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75008, encodeId=9234e500889, content=终于有了, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Thu Mar 31 12:44:00 CST 2016, time=2016-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75007, encodeId=bd82e5007a2, content=非常的好, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Thu Mar 31 12:43:00 CST 2016, time=2016-03-31, status=1, ipAttribution=)]
    2016-03-31 Lisa971

    中药编码,有利于药物管理和查询。

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1951321, encodeId=7fd7195132134, content=<a href='/topic/show?id=18ad4112322' target=_blank style='color:#2F92EE;'>#国际标准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41123, encryptionId=18ad4112322, topicName=国际标准)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=570c172, createdName=tigerlr98, createdTime=Fri Jul 08 20:27:00 CST 2016, time=2016-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1584638, encodeId=b297158463808, content=<a href='/topic/show?id=83f5e9250e9' target=_blank style='color:#2F92EE;'>#编码#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79250, encryptionId=83f5e9250e9, topicName=编码)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b10a17056098, createdName=12498f6em12暂无昵称, createdTime=Sat Apr 02 00:27:00 CST 2016, time=2016-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75036, encodeId=aaece503661, content=中药编码,有利于药物管理和查询。, beContent=null, objectType=article, channel=null, level=null, likeNumber=171, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160313/IMG56E50DEC424F44672.jpg, createdBy=ce5b1699635, createdName=Lisa971, createdTime=Thu Mar 31 16:18:00 CST 2016, time=2016-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75035, encodeId=81dde5035b4, content=中药编码,有利于药物的管理,查询!, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160313/IMG56E50DEC424F44672.jpg, createdBy=ce5b1699635, createdName=Lisa971, createdTime=Thu Mar 31 16:14:00 CST 2016, time=2016-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75008, encodeId=9234e500889, content=终于有了, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Thu Mar 31 12:44:00 CST 2016, time=2016-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75007, encodeId=bd82e5007a2, content=非常的好, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Thu Mar 31 12:43:00 CST 2016, time=2016-03-31, status=1, ipAttribution=)]
    2016-03-31 Lisa971

    中药编码,有利于药物的管理,查询!

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1951321, encodeId=7fd7195132134, content=<a href='/topic/show?id=18ad4112322' target=_blank style='color:#2F92EE;'>#国际标准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41123, encryptionId=18ad4112322, topicName=国际标准)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=570c172, createdName=tigerlr98, createdTime=Fri Jul 08 20:27:00 CST 2016, time=2016-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1584638, encodeId=b297158463808, content=<a href='/topic/show?id=83f5e9250e9' target=_blank style='color:#2F92EE;'>#编码#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79250, encryptionId=83f5e9250e9, topicName=编码)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b10a17056098, createdName=12498f6em12暂无昵称, createdTime=Sat Apr 02 00:27:00 CST 2016, time=2016-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75036, encodeId=aaece503661, content=中药编码,有利于药物管理和查询。, beContent=null, objectType=article, channel=null, level=null, likeNumber=171, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160313/IMG56E50DEC424F44672.jpg, createdBy=ce5b1699635, createdName=Lisa971, createdTime=Thu Mar 31 16:18:00 CST 2016, time=2016-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75035, encodeId=81dde5035b4, content=中药编码,有利于药物的管理,查询!, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160313/IMG56E50DEC424F44672.jpg, createdBy=ce5b1699635, createdName=Lisa971, createdTime=Thu Mar 31 16:14:00 CST 2016, time=2016-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75008, encodeId=9234e500889, content=终于有了, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Thu Mar 31 12:44:00 CST 2016, time=2016-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75007, encodeId=bd82e5007a2, content=非常的好, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Thu Mar 31 12:43:00 CST 2016, time=2016-03-31, status=1, ipAttribution=)]
    2016-03-31 milkshark

    终于有了

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1951321, encodeId=7fd7195132134, content=<a href='/topic/show?id=18ad4112322' target=_blank style='color:#2F92EE;'>#国际标准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41123, encryptionId=18ad4112322, topicName=国际标准)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=570c172, createdName=tigerlr98, createdTime=Fri Jul 08 20:27:00 CST 2016, time=2016-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1584638, encodeId=b297158463808, content=<a href='/topic/show?id=83f5e9250e9' target=_blank style='color:#2F92EE;'>#编码#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79250, encryptionId=83f5e9250e9, topicName=编码)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b10a17056098, createdName=12498f6em12暂无昵称, createdTime=Sat Apr 02 00:27:00 CST 2016, time=2016-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75036, encodeId=aaece503661, content=中药编码,有利于药物管理和查询。, beContent=null, objectType=article, channel=null, level=null, likeNumber=171, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160313/IMG56E50DEC424F44672.jpg, createdBy=ce5b1699635, createdName=Lisa971, createdTime=Thu Mar 31 16:18:00 CST 2016, time=2016-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75035, encodeId=81dde5035b4, content=中药编码,有利于药物的管理,查询!, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160313/IMG56E50DEC424F44672.jpg, createdBy=ce5b1699635, createdName=Lisa971, createdTime=Thu Mar 31 16:14:00 CST 2016, time=2016-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75008, encodeId=9234e500889, content=终于有了, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Thu Mar 31 12:44:00 CST 2016, time=2016-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=75007, encodeId=bd82e5007a2, content=非常的好, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Thu Mar 31 12:43:00 CST 2016, time=2016-03-31, status=1, ipAttribution=)]
    2016-03-31 milkshark

    非常的好

    0

相关资讯

王承德委员:越是有毒的中药越是好药

昨日的全国政协十二届四次会议医卫界别联组会议发言,全国政协委员、北京顺天德中医医院院长王承德的一番话,惊倒了会场上许多人。 说到现在中药制剂审批程序繁冗,王承德说,一个新制剂要进入临床应用,必须小白鼠点头才能通过,而中医药专家的话都不算数。他建议将中药制剂审批制度改为备案制,让更多的中医自制药用于普通患者。 “凡是药都有毒性,越是有毒的药越是好药。”王承德说,中医的毒性药治了许多西医治

CFDA叫停中药提取委托加工,但行业影响有限

近日,CFDA发布《关于落实中药提取和提取物监督管理有关规定的公告》,要求自今年1月1日起,凡不具备中药前处理和提取能力的中成药生产企业,停止相应中药品种的生产,逾期不停产将依据《药品管理法》严肃查处;同时,生产使用中药提取物必须备案。 “中药提取委托加工被叫停在行业内酝酿已久,也符合预期,且经历了过渡期,落地执行是水到渠成,不会造成‘大震动’。”有行业人士在接受本报记者采访时表示。 据悉

Nature子刊:体外实验证实——中药岩蔷薇强效抵抗HIV和埃博拉病毒

在一项新的研究中,来自德国亥姆霍兹慕尼黑中心的研究人员发现药用植物白瑞木(Cistus incanus,也译作灰白岩蔷薇)的提取物阻止人免疫缺陷病毒(HIV)感染细胞。这种提取物中的抗病毒活性成分抑制HIV病毒蛋白停泊到细胞上。这种提取物中的抗病毒成分也具有抗埃博拉病毒和马尔堡病毒的作用。相关研究结果于2016年2月2日在线发表在Scientific Reports期刊上,论文标题为“Pote

CFDA:批准12个品种为首家中药二级保护品种,11个品种延长保护期

1月21日,根据《中药品种保护条例》的规定,CFDA宣布批准了12个中药品种为首家中药二级保护品种,保护期限自公告日起七年,并给予11家企业生产的11个中药保护品种继续给予延长保护期。 同时,CFDA表示,同品种生产企业应按《中药品种保护条例》及有关规定申报同品种保护,逾期不申报的,应停止生产;若继续生产,国家食品药品监督管理总局将中止其批准文号效力,并按《中药品种保护条例》第二十三条的有关

食药监管总局公布2015年度药品上市批准情况

为进一步提高药品审评审批透明度,有效指导药物研发申报及药品临床应用,食品药品监管总局日前发布公告,公布了《2015年批准上市的中药、天然药物目录》、《2015年批准上市的化学药品目录》、《2015年批准上市的生物制品目录》。   据统计,2015年度食品药品监管总局共批准中药、天然药物上市注册申请76个,化学药品上市注册申请241个,生物制品上市注册申请25个。详细信息请查阅《国

国务院印发未来十五年中医药发展战略规划纲要

经李克强总理签批,国务院日前印发《中医药发展战略规划纲要(2016—2030年)》(以下简称《纲要》)。《纲要》明确了未来十五年我国中医药发展方向和工作重点,是新时期推进我国中医药事业发展的纲领性文件。 《纲要》提出,要坚持中西医并重,落实中医药与西医药的平等地位,遵循中医药发展规律,以推进继承创新为主题,以提高中医药发展水平为中心,以完善符合中医药特点的管理体制和政策机制为重点,以增进和维护人